Back
Avenue Therapeutics Stock Price Chart
Sponsored
ATXI
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
14
ATXI
Avenue Therapeutics
Last Price:
2.61
Seasonality Move:
-29.84%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.
Avenue Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.78 | Sell |
20-day SMA: | 2.76 | Sell |
50-day SMA: | 2.86 | Sell |
200-day SMA: | 7.38 | Sell |
8-day EMA: | 2.74 | Sell |
20-day EMA: | 2.76 | Sell |
50-day EMA: | 3.03 | Sell |
200-day EMA: | 18.15 | Sell |
Avenue Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 41.79 | Sell |
Chaikin Money Flow: | -9097 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.61 - 2.91) | Sell |
Bollinger Bands (100): | (2.71 - 3.91) | Sell |
Avenue Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Avenue Therapeutics Stock
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 2.61 while ATXI 8-day simple moving average is 2.78, which is a Sell signal.
- The stock price of ATXI is 2.61 while Avenue Therapeutics 20-day SMA is 2.76, which makes it a Sell.
- Avenue Therapeutics 50-day simple moving average is 2.86 while ATXI share price is 2.61, making it a Sell technically.
- ATXI stock price is 2.61 and Avenue Therapeutics 200-day simple moving average is 7.38, creating a Sell signal.
ATXI Technical Analysis vs Fundamental Analysis
Sell
14
Avenue Therapeutics (ATXI)
is a Sell
Is Avenue Therapeutics a Buy or a Sell?
-
Avenue Therapeutics stock is rated a Sell
The current Avenue Therapeutics [ATXI] share price is $2.61. The Score for ATXI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Avenue Therapeutics Stock Info
Market Cap:
3.74M
Price in USD:
2.61
Share Volume:
10.5K
Avenue Therapeutics 52-Week Range
52-Week High:
54.74
52-Week Low:
2.25
Sell
14
Avenue Therapeutics (ATXI)
is a Sell
Avenue Therapeutics Share Price Forecast
-
What is the Avenue Therapeutics stock price today?
The Avenue Therapeutics stock price is 2.61 USD today. -
Will ATXI stock go up or go down?
Avenue Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Avenue Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avenue Therapeutics is overvalued.
Is Avenue Therapeutics Stock a Buy?
- Avenue Therapeutics share price is 2.61 while ATXI 8-day exponential moving average is 2.74, which is a Sell signal.
- The stock price of ATXI is 2.61 while Avenue Therapeutics 20-day EMA is 2.76, which makes it a Sell.
- Avenue Therapeutics 50-day exponential moving average is 3.03 while ATXI share price is 2.61, making it a Sell technically.
- ATXI stock price is 2.61 and Avenue Therapeutics 200-day simple moving average is 18.15, creating a Sell signal.
Technical Analysis of Avenue Therapeutics
Should I short Avenue Therapeutics stock?
- ATXI Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Avenue Therapeutics is a Sell
- Avenue Therapeutics Relative Strength Index (RSI) is 41.79, which suggest Avenue Therapeutics is oversold
- The Bollinger Bands (25) for Avenue Therapeutics is (2.61 - 2.91), which suggest Avenue Therapeutics is a Sell
- The Bollinger Bands (100) for Avenue Therapeutics is (2.71 - 3.91), which suggest Avenue Therapeutics is a Sell
* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.